drugset / Trial / NCT00206739

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

NCT00206739

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess the effectiveness of Intermittent Preventive Treatment in Infants (IPTi) with Sulfadoxine-Pyrimethamine to reduce the numbers of malaria attacks, episodes of anemia, and the overall morbidity and mortality

Timeline

Start
2003-01
Primary completion
2005-09
Completion
2005-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject pyrimethamine Small molecule 250 mg
Subject sulfadoxine Small molecule 12.5 mg

Indications